ALKS-6931

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameALKS-6931
Drug Alias NameALKS-6931
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionHigh affinity immunoglobulin gamma Fc receptor I agonistsTumor necrosis factor agonists
TargetsTumor necrosis factorHigh affinity immunoglobulin gamma Fc receptor I
Therapy Area/IndicationsAutoimmune DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlkermes Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlkermes Plc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A